Prescryptive Health’s chief commercial officer discusses the results of a market access survey that asked industry executives about DTC models, affordability, and patient access.
Cam Olig
Advertisement
Cam brings more than 30 years of experience in health-plan, pharmacy benefit, and consulting markets. Before joining Prescryptive, Cam spent 17 years at Prime Therapeutics as Senior Vice President of Commercial and Government Markets. In that role, he led sales and account-management teams, helping Prime Therapeutics grow to manage over $30 billion in drug spend. Prior to Prime Therapeutics, Cam worked as a partner at WTW (formerly Towers Perrin), where he led the health-and-welfare consulting practice.
Articles by Cam Olig
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
2
FDA Sends CRL to Cingulate for CTx-1301
3
FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy
4
FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer
5